130 studies found for:    Open Studies | "Colonic Diseases, Functional"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Not yet recruiting Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery
Conditions: Irritable Bowel Syndrome;   Abdominal Pain;   Colonic Diseases, Functional
Interventions: Drug: Tempocol-ColoPulse® (Peppermint oil);   Drug: Placebo;   Drug: Tempocol® (Peppermint oil)
2 Recruiting fMRI and Visceral Perception Upon Capsaicin Infusion
Conditions: Irritable Bowel Syndrome;   Colonic Diseases, Functional;   Dyspepsia;   Gastrointestinal Diseases;   Abdominal Pain;   Visceral Pain
Interventions: Other: Capsaicin;   Other: Placebo
3 Recruiting Randomized Placebo Controlled Phase 2 Trial of Bekinda (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Condition: Irritable Bowel Syndrome With Diarrhea
Interventions: Drug: BEKINDA;   Drug: Placebo
4 Recruiting Patient-Centred Innovations for Persons With Multimorbidity - Ontario
Conditions: Hypertension;   Depression;   Anxiety;   Musculoskeletal Pain;   Arthritis;   Rheumatoid Arthritis;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Asthma;   Chronic Bronchitis;   Cardiovascular Disease;   Heart Failure;   Stroke;   Transient Ischemic Attacks;   Ulcer;   Gastroesophageal Reflux;   Irritable Bowel;   Crohn's Disease;   Ulcerative Colitis;   Diverticulosis;   Chronic Hepatitis;   Diabetes;   Thyroid Disorder;   Cancer;   Kidney Disease;   Urinary Tract Problem;   Dementia;   Alzheimer's Disease;   Hyperlipidemia;   HIV;   Multimorbidity
Intervention: Behavioral: TIP / IMPACT Plus Care Coordination
5 Recruiting Food Supplement Physiomanna® Baby in Pediatric Patients
Condition: Irritable Bowel Syndrome Characterized by Constipation
Intervention: Dietary Supplement: Physiomanna® Baby
6 Recruiting Lactibiane Tolérance® in Individuals Suffering From Irritable Bowel Syndrome With Diarrheal Predominance
Condition: Diarrhea Predominant Irritable Bowel Syndrome
Intervention: Dietary Supplement: Lactibiane Tolerance
7 Recruiting A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Intervention: Drug: Tenapanor
8 Recruiting Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Condition: Neurogenic Bowel
Intervention: Device: Navina Smart
9 Recruiting Long Term Safety Study of Plecanatide
Condition: Irritable Bowel Syndrome
Intervention: Drug: Plecanatide
10 Recruiting Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
Conditions: Irritable Bowel Syndrome;   Ulcerative Colitis;   Inflammatory Bowel Disease
11 Recruiting A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Interventions: Drug: Tenapanor;   Drug: Placebo
12 Recruiting Mindfulness-based Eating in Patients With Irritable Bowel Syndrome
Conditions: Abdominal Pain;   Irritable Bowel Syndrome;   IBS
Interventions: Dietary Supplement: Dietary intervention;   Behavioral: Irritable Bowel Syndrome eating awareness training
13 Recruiting Retrospective Study of IBS-D Patients Previously Receiving SBI
Condition: Diarrhoea Predominant Irritable Bowel Syndrome
Intervention: Other: EnteraGam
14 Recruiting Gut Microbiota Reconstruction for the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Drug: placebo;   Drug: Rifaximin;   Procedure: infusing saline through enteral nutrition tube;   Procedure: FMT with donor stool through enteral nutrition tube
15 Recruiting Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome (IBS)
Intervention: Device: Confocal Laser Endomicroscopy
16 Not yet recruiting Afferent Stimulation to Evoke Recto-colonic Reflex for Colonic Motility
Condition: Neurogenic Bowel Dysfunction
Intervention: Other: Electrical Rectal Stimulation
17 Not yet recruiting Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention: Drug: Amitriptyline
18 Recruiting A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Interventions: Drug: Tenapanor;   Drug: Placebo
19 Recruiting Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Condition: Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Interventions: Drug: Clostridium Butyricum;   Drug: placebo
20 Not yet recruiting Fructose Breath-testing in Irritable Bowel Syndrome (IBS)
Conditions: Functional Gastrointestinal Disorders;   Irritable Bowel Syndrome
Interventions: Procedure: Open breath test with fructose;   Procedure: Breath test with sweet placebo (Assugrin);   Procedure: Breath test with neutral placebo (still water);   Procedure: Blinded breath test with fructose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years